PHIO PHARMACEUTICALS CORP. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
PHIO PHARMACEUTICALS CORP. (PHIO) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $30.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-03-05
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $30.00K.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-03-31 was $4.00K, a 84.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2023-03-31 was $25.00K, a 0.00% change year-over-year.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-09-30 was $3.00K.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $30.00K, a 500.00% increase from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $5.00K, a 80.77% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $26.00K, a 7.14% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $28.00K, a 2700.00% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|
| 2025-12-31 | $30.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $5.00K 10-K · filed 2026-03-05 | |
| 2024-03-31 | $4.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $26.00K 10-K · filed 2025-03-31 | |
| 2023-03-31 | $25.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $28.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $3.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $25.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $1.00K 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |